Introduction: To Year 2026 Pancreatic Cancer Stats

It’s important to note that the following pancreatic cancer stats represent a relative average of survival and death rates. Each pancreatic cancer patient is different, and the treatment options that perform best for each patient, as well as their responses and results, will vary depending on many factors.

The earlier pancreatic cancer is diagnosed, the better the prognosis. Unfortunately, pancreatic cancer usually shows few impressive signs and symptoms, if any at all, until the cancer has already advanced to later stages beyond the pancreas, when surgical removal of the cancerous tumor is no longer possible. It becomes progressively more difficult to treat, which leads to greater mortality rates.

Pancreatic cancer is especially aggressive and difficult to treat, making it one of the most formidable cancers in the United States. In 2026, about 67,530 Americans are expected to receive this diagnosis, and tragically, roughly 52,740 will lose their lives to the disease. The narrow margin between new cases and deaths underscores just how deadly pancreatic cancer still is, despite advances in medicine.

Though pancreatic cancer makes up only around 3.3% of all new cancer cases, it ranks as the third leading cause of cancer-related deaths, trailing only lung and colorectal cancers. This imbalance highlights the disease’s low survival rate and the challenge of catching it early—often, it isn’t discovered until it has advanced, when treatment options are limited.

5-Year Average Survival Has Increased To 13% in 2026

The overall 5-year survival rate for pancreatic cancer is just 13%. In other words, only about 1 in 8 people diagnosed with this disease are still alive five years later. This sobering statistic is mostly because pancreatic cancer is typically found after it has already progressed to an advanced stage, making it much harder to treat successfully.

Survival odds change dramatically depending on how far the cancer has spread at the time of diagnosis:

• Localized (44%): If the cancer is caught while it’s still confined to the pancreas, nearly half of patients will reach the five-year survival mark. This shows just how important early detection is.
• Regional (17%): Once it spreads to nearby tissues or lymph nodes, survival rates drop sharply.
• Distant (3%): If the cancer has reached distant organs, long-term survival is unfortunately very rare.

These differences illustrate that the stage at diagnosis is one of the most important factors influencing outcomes.

Age and Risk Patterns

Pancreatic cancer is largely a disease of older adults. The median age at diagnosis is 71, meaning half of the patients are diagnosed before this age and half after. Most cases occur between ages 65 and 74, indicating that risk increases significantly with age.

Pancreatic Cancer Stats Source: Seer.Cancer.Gov

Trends Over Time

Pancreatic cancer is not only deadly but also becoming more common. Incidence has been increasing by about 1% per year for several decades. This steady rise suggests that, despite advances in medicine, underlying risk factors and detection challenges continue to drive growth in cases.

Why Early Detection Matters

One of the biggest challenges with pancreatic cancer is that it is rarely caught early. Symptoms are often vague, such as abdominal discomfort, weight loss, or fatigue, or may not appear until the disease has already spread. Because of this, most patients are diagnosed at later stages, when treatment options are more limited.
​
Routine screening is not recommended for the general population, but individuals with a strong family history or certain genetic mutations may benefit from specialized monitoring programs.
​

Sources of Pancreatic Cancer Stats

National Cancer Institute
American Cancer Society
Johns Hopkins Medicine